Skip to content
BillRazor
Generic

CLOBETASOL 0.05% OINTMENT

CLOBETASOL 0.05% OINTMENT, a generic topical corticosteroid, has a Medicare acquisition cost of $0.19 per unit, though hospital charges can reach 10-50 times this benchmark amount.

By Elena Vasquez , Medical Billing Research Lead · ·
Data from CMS files published FY 2024 CMS IPPS. Refreshed weekly.
About the analyst

Elena Vasquez leads hospital billing pattern analysis at BillRazor Research. She focuses on identifying overcharges, markup outliers, and patient advocacy strategies. Expertise: hospital billing patterns, overcharge analysis, patient advocacy.

NADAC acquisition cost data
CMS drug pricing benchmarks
Updated 2026-04-03
Drug acquisition cost — CLOBETASOL 0.05% OINTMENT
NADAC cost$0.1862 per unit
Hospital charges for this drug vary — typically 3–8x the acquisition cost. No observed hospital charge data is available for this specific drug.
$0.19
NADAC acquisition cost
CREAM
Dosage form
TOPICAL
Route

Clobetasol 0.05% ointment is a high-potency topical corticosteroid prescribed for severe inflammatory skin conditions like psoriasis and eczema. As a generic medication, billing codes vary by tube size, with the 15g and 30g presentations having different reimbursement rates across insurance plans.

Check your bill amount
Enter the charge for CLOBETASOL 0.05% OINTMENT from your bill to compare against the NADAC acquisition cost.
$

No credit card required. Results in 60 seconds.

Research suggests 49–80% of hospital bills contain errors. Our system checks every line item against Medicare benchmarks.
Rates shown are from the 2026 Medicare Physician Fee Schedule and CMS IPPS. BillRazor compares your bill against these data sources. See how it works →

Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.

What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.

Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.

Upload your bill — free instant analysis